SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news

 

 
UK ASA Ruling

UK regulator turns ‘contrary’ over infant drink marketing, says campaigner

By Nicola Cottam , 24-Jun-2014

Baby Milk Action: “The ASA...is now taking a view totally contrary to Department of Health guidance notes.”
Baby Milk Action: “The ASA...is now taking a view totally contrary to Department of Health guidance notes.”

Danone Nutricia’s vindication from any wrongdoing in press adverts for Aptamil with Pronutra+ follow-on milk was described as “absurd” by Baby Milk Action (BMA), which filed a complaint with the UK’s Advertising Standards Authority (ASA) following numerous complaints from consumers.

BMA campaigns co-ordinator Mike Brady said the complaint was dismissed on a technicality although the adverts clearly breach guidance notes.

“The fact that the ASA has not upheld the complaint on a technicality shows the absurdity of the system. The adverts clearly infringe Infant Formula and Follow-on Formula Regulations (2007),” said Brady of the laws that prevent all marketing of formulas designed for infants under 6-months.

“The ASA had previously acknowledged there was a problem with the ads and is now taking a view totally contrary to Department of Health guidance notes.”

Ruling raises questions

The BMA has been challenging claims on press adverts that suggest Aptamil with Pronutra+ has the same benefits as breast milk, although the main issue concerns the lack of reference to the product as a follow-on formula.

The 6-month marketing campaign involved four adverts that highlighted the product’s nutritional and health benefits, however only one advert mentioned the product was a follow-on formula, as opposed to an infant formula.

Three complainants, including BMA’s, suggested this was misleading and breached UK advertising regulations, although these have been rejected by the ASA.

“The ASA is using one advert [that refers to the product as a follow-on formula] as an excuse to exonerate the problems with the other three,” said Brady.

“This ruling raises questions about how regulations in this area are being applied by the ASA, Department of Health and local authorities.”

Health claims upheld

The ASA also disregarded complaints concerning the ambiguous nature of health claims, although it did suggest some fine-tuning was necessary.

It stated, “we considered the claims were likely to be interpreted to mean that Aptamil Pronutra+ Follow On milk contained some of the same substances as breast milk.”

Nevertheless, the authority upheld claims implying similarities between Aptamil with Pronutra+ and breast milk, saying statements were not misleading because they explained product development was ongoing and that further research was necessary into breast milk.

Pro-breastfeeding BMA now intends to pursue the matter through UK parliamentary channels, said Brady.

This is the second time in just over a week that Danone Nutricia has been probed by the ASA over questionable advertising claims, although in the previous case – involving claims about vitamin D in ‘Growing up milk’- the ruling was upheld.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars